08048035996
Acalnib Capsules UK Wholesale – Leeds | Competitive Prices | Phoenix Exim | Trusted Exporter

1. General Information

Acalnib 100 mg Capsule contains acalabrutinib, a targeted anticancer medicine belonging to the Bruton’s tyrosine kinase (BTK) inhibitor class. It is used in adults for certain blood cancers, including chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and mantle cell lymphoma (MCL) in appropriate clinical situations.

Acalnib is a prescription medicine and treatment should be individualized by an oncologist based on the patient's condition, previous treatment and other medicines.

2. Product Information

ProductAcalnib 100 mg Capsule
Active ingredientAcalabrutinib 100 mg
Dosage formCapsule
Therapeutic classAntineoplastic / kinase inhibitor
Drug classBTK inhibitor
AdministrationOral
Prescription statusPrescription medicine
Common pack30 capsules

Acalnib 100 mg is marketed in India by Hetero Healthcare Pvt Ltd, according to current product listings.

3. Uses of Acalnib

Acalnib 100 mg may be prescribed for:

  • Chronic lymphocytic leukemia (CLL)
  • Small lymphocytic lymphoma (SLL)
  • Mantle cell lymphoma (MCL) in appropriate patients, including certain patients who have received previous therapy.

The exact indication and treatment regimen should always be determined by the treating oncologist.

4. Benefits of Acalnib

Acalnib provides targeted treatment for certain B-cell blood cancers. Its principal therapeutic benefit is its ability to interfere with signaling pathways that help malignant B cells survive and multiply.

Unlike conventional chemotherapy, acalabrutinib is a targeted therapy, designed to inhibit BTK activity involved in B-cell receptor signaling. This can help slow the growth and progression of susceptible cancer cells.

5. Side Effects of Acalnib

Like other anticancer medicines, Acalnib can cause side effects. Some important adverse effects can include:

  • Anemia
  • Low neutrophil count
  • Low platelet count
  • Upper respiratory tract infections
  • Headache
  • Diarrhea
  • Muscle, bone or joint pain
  • Fatigue
  • Nausea

Acalabrutinib can also cause clinically important problems such as bleeding, infections, low blood-cell counts and heart-related complications in some patients.

Seek medical attention promptly for unusual or significant bleeding, severe infection symptoms, or other serious or persistent reactions.

6. Common Side Effects

Some commonly reported side effects include:

  1. Anemia – reduced red blood cell count
  2. Neutropenia – reduced neutrophil count
  3. Thrombocytopenia – reduced platelet count
  4. Upper respiratory tract infection
  5. Headache
  6. Diarrhea
  7. Musculoskeletal pain

The severity and occurrence of side effects vary from patient to patient.

7. How to Use Acalnib

Take Acalnib exactly as prescribed by your oncologist.

  • Swallow the capsule whole with water.
  • Do not crush, chew or break the capsule.
  • It may generally be taken with or without food.
  • Take it at the prescribed times each day.
  • Do not change the dose or stop treatment without consulting your doctor.
  • If you miss a dose, follow your doctor's or product-label instructions rather than taking an extra dose.

Because dosing can vary according to the indication and other medicines being taken, the prescribed regimen should take priority.

8. How Acalnib Works

Acalnib contains acalabrutinib, which inhibits Bruton's tyrosine kinase (BTK).

BTK is involved in signaling pathways that help certain B cells grow, survive and communicate. By blocking BTK signaling, acalabrutinib can interfere with the survival and multiplication of malignant B cells, helping to control the cancer.

9. Safety Advice

Pregnancy: Acalabrutinib may cause fetal harm. Women who can become pregnant should discuss effective contraception with their healthcare provider.

Breastfeeding: Breastfeeding is generally not recommended during treatment; discuss this with the treating physician.

Bleeding: Acalabrutinib can increase bleeding risk. Inform your doctor about blood thinners, antiplatelet medicines, NSAIDs and any planned surgery or dental procedure.

Infections: Treatment can reduce certain blood-cell counts and may increase susceptibility to infections. Report fever or other signs of infection promptly.

Heart: Tell your doctor if you have a history of heart problems because cardiac complications can occur.

Liver and kidney disease: Inform your doctor about existing liver or kidney problems; additional caution or monitoring may be required.

Drug interactions: Acalabrutinib can interact with several medicines, including some antibiotics, antifungals, HIV medicines and medicines affecting stomach acid. Always provide your doctor with a complete list of medicines and supplements you take.

Monitoring: Doctors may perform regular blood tests to monitor blood-cell counts and assess organ function during treatment.

10. Frequently Asked Questions

Q1. What is Acalnib 100 mg used for?
Acalnib 100 mg is used for certain blood cancers, including CLL, SLL and MCL in appropriate patients.

Q2. What is the active ingredient in Acalnib?
The active ingredient is acalabrutinib 100 mg.

Q3. Is Acalnib a chemotherapy medicine?
Acalnib is a targeted anticancer therapy, specifically a BTK inhibitor, rather than conventional cytotoxic chemotherapy.

Q4. Can Acalnib be taken without a prescription?
No. It is a prescription anticancer medicine and should be taken only under specialist medical supervision.

Q5. Can I stop Acalnib when I feel better?
No. Do not discontinue treatment without consulting your oncologist.

Q6. Does Acalnib cause low blood counts?
Yes. Anemia, neutropenia and thrombocytopenia are among the reported adverse effects, so blood-count monitoring may be required.

Q7. Can Acalnib interact with other medicines?
Yes. Several medicines can affect acalabrutinib levels or increase adverse-effect risks. Tell your doctor about all prescription, OTC and herbal products you use.

Q8. How should Acalnib be stored?
Follow the manufacturer's storage instructions and keep the medicine in a dry place, protected from inappropriate temperatures, moisture and direct sunlight. Keep it away from children.

11. Substitutes for Acalnib

Products containing the same active ingredient and strength (acalabrutinib 100 mg) may be available under different brand names. Current Indian listings include examples such as:

  • Acabrunat 100 mg Capsule
  • Betatinib 100 mg Capsule
  • Admaone 100 mg Capsule
  • Acaone 100 mg Capsule
  • Capbrusam 100 mg Capsule
  • Calquence 100 mg Capsule (reference brand)

These are not interchangeable on your own. The doctor or pharmacist should confirm the appropriate product, strength, formulation and indication before substitution.

12. SEO & B2B Keywords

For Phoenix Exim's international B2B catalog, you can use keywords such as:

  • Acalnib 100 mg Capsule exporter from India
  • Acalnib 100 mg supplier India
  • Acalabrutinib 100 mg Capsule exporter
  • Acalabrutinib medicine supplier from India
  • Acalnib 100 mg pharmaceutical exporter
  • Acalnib capsules wholesale supplier
  • Acalnib 100 mg bulk supplier
  • Acalabrutinib oncology medicine exporter
  • Acalnib 100 mg export from Nagpur
  • Acalnib 100 mg supplier Nagpur India
  • Acalnib 100 mg for CLL
  • Acalnib 100 mg for SLL
  • Acalnib 100 mg for mantle cell lymphoma
  • Acalabrutinib capsules wholesale India
  • Acalabrutinib 100 mg generic supplier
  • Acalnib 100 mg international supplier
  • Acalnib capsules export to USA
  • Acalnib capsules export to UK
  • Acalnib capsules export to Australia
  • Acalnib capsules export to Singapore
  • Acalnib capsules export to Canada
  • Acalnib capsules export to South Korea
  • Acalnib capsules export to UAE
  • Acalabrutinib supplier for USA
  • Acalabrutinib supplier for UK
  • Acalabrutinib supplier for Australia
  • Acalabrutinib supplier for Canada
  • Acalabrutinib supplier for UAE
  • Acalabrutinib oncology pharmaceutical supplier
  • Acalnib 100 mg B2B pharmaceutical supplier
  • Phoenix Exim Acalnib 100 mg exporter India
Aug 12th, 2026 3:24 PM

Keywords